Clinical Trials Sponsored by Marcus Maurer

Total 3726 results

Aarhus University Hospital
University of Aarhus

Completed

Delirium in Geriatric Hospital Single-bed and Multibed Rooms

Delirium | Older Patients | Admittance to Single-bed Rooms or Multi-bed Rooms

Denmark
University of Aarhus
Aarhus University Hospital

Completed

Electrophysiological Optimization of Left Ventricular Lead Placement in CRT (ElectroCRT)

Congestive Heart Failure

Denmark
University of Aarhus
Aarhus University Hospital

Unknown

Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis

Myasthenia Gravis

Denmark
Aarhus University Hospital
University of Aarhus

Completed

Informant Questionaire on Cognitive Decline in the Elderly (IQCODE) and Delirium in Geriatric Patients (Delirium)

Cognitive Decline | Delirium in Old Age

Denmark
Aarhus University Hospital
University of Aarhus

Completed

Geriatrician-performed Comprehensive Geriatric Care in an Outpatient Community Rehabilitation Unit (GCGCCRU)

Fragility

Denmark
University of Aarhus
Aarhus University Hospital

Completed

"GOLIATH" - General Or Local Anaestesia in Intra Arterial THerapy (GOLIATH)

Stroke | Anesthesia | Cerebral Revascularization

Denmark
Aarhus University Hospital
University of Aarhus

Completed

Effect of Arabinoxylan and Rye Kernels on Second Meal Responses

Metabolic Syndrome

Denmark
Aarhus University Hospital
University of Aarhus

Completed

ButCoIns - Metabolic Effects of Resistent Starch and Arabinoxylans in Subjects With Metabolic Syndrome (ButCoIns)

Metabolic Syndrome

Denmark
Aarhus University Hospital

Completed

Movement Pattern in Patients With Hip Dysplasia

Hip Dysplasia

Denmark
University of Aarhus
Aarhus University Hospital

Completed

An Innovational Model to Manage Patient Expectations and Improve Patient Satisfaction: An Intervention Study

Patient Satisfaction | Patient-Centered Care

Denmark
Aarhus University Hospital

Unknown

Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals

Atrophic Acne Scars

Denmark
University of Aarhus
Aarhus University Hospital

Completed

Saphenous Nerve Block: Single Shot Versus Continuous Infusion to Supplement a Continuous Sciatic Nerve Block After Major Ankle Surgery

Major Ankle Surgery

Denmark
University of Aarhus
Aarhus University Hospital

Withdrawn

Sildenafil for Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension

Pulmonary Hypertension | COPD

Denmark
Aarhus University Hospital
University of Aarhus

Completed

Effect of Dietary Fibre and Whole Grain on the Metabolic Syndrome

Metabolic Syndrome

Denmark
University of Aarhus
Aarhus University Hospital

Completed

Dose-response Relationship of Phototherapy for Hyperbilirubinaemia Using Diodes: is There a "Saturation Point"

Neonatal Hyperbilirubinemia

Denmark
University of Aarhus
Aarhus University Hospital

Completed

Eosinophil Markers and Development of Disease in Allergic Rhinitis

Seasonal Allergic Rhinitis
University of Aarhus
Aarhus County, Denmark

Completed

Effect of Passive Gait Training on the Cortical Activity in Patients With Severe Traumatic Brain Injury.

Craniocerebral Trauma | Traumatic Brain Injury | "Rehabilitation"

Denmark
University of Aarhus
Aarhus University Hospital

Completed

Bioavailability of Insulin Administered in Duodenum

Diabetes Mellitus

Denmark
University Hospitals Cleveland Medical Center
Melissa March; Alison Bauer; Gaetan Pettigrew; Daisy Hassani; Celina Cunanan

Withdrawn

Effect of a Commercially Available Carbohydrate Rich Gel on Maternal Fatigue: A Randomized Controlled Trial

Effect of Carbohydrate Ingestion During Active Labor
Exelixis
Arcus Biosciences, Inc.

Recruiting

Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009)

Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors

United States
Magnus Medical

Not yet recruiting

SAINT for MDD in an Inpatient Setting Follow-on

Suicidal Ideation | Major Depressive Disorder | Major Depressive Episode

United States
Tarsus University

Not yet recruiting

The Effect of Playing With a Toy Nebulizer and Watching Cartoons on the Fear and Anxiety on Children

Anxiety | Fear | Inhalant Use

Turkey
Tarsus University

Recruiting

The Effect of Mother's Smell and Breast Milk Smell on Pain

Pain | Newborn; Vitality | Crying

Turkey
Tarsus University

Recruiting

Effectiveness of Pilates and Taping in Office Workers With Neck Pain

Neck Pain

Turkey
Tarsus University

Recruiting

The Effect of the Continuous Midwifery Care Model on Birth Outcomes

Pregnancy Related | Birth, First | Trauma, Psychological | Birth Trauma | Newborn; Fit

Turkey
Tarsus University

Not yet recruiting

The Effect of Mixed Reality Technology-Based Breastfeeding Counseling on Breastfeeding Success and Self-Efficacy of Women

Pregnancy Related | Breastfeeding | Breast Milk Expression
Amicus Therapeutics

Recruiting

A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

Fabry Disease

United States
Amicus Therapeutics

Recruiting

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

Pompe Disease (Late-onset)

United States, Japan, Australia, Taiwan, Canada
Tarsus University

Active, not recruiting

Effect Of Functional Balance Exercise İn Elderly (RCT)

Exercise | Older People

Turkey
Marinus Pharmaceuticals

Active, not recruiting

Randomized Therapy In Status Epilepticus (RAISE)

Status Epilepticus

United States, Australia, Canada
Marinus Pharmaceuticals

Enrolling by invitation

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Tuberous Sclerosis Complex

United States, Spain, United Kingdom, China, Italy, France, Israel, Germany, Canada, Australia
Amicus Therapeutics

Active, not recruiting

A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With LOPD

Pompe Disease (Late-onset)

United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
Tarsus University

Completed

The Effect of the Helper Skin Tap Technique and Buzzy® During Vaccination

Child, Only

Turkey
Tarsus University

Completed

ShotBloker and Helfer Skin Tap Technique During Intramuscular Injection in Children

Emergencies | Pain, Acute | Fear | Child, Only | Injection Fear

Turkey
Tarsus University

Completed

The Effect of Cold Spray and Ice Applied During Intravenous Access on Pain and Fear i in Pediatric Emergency Unit

Pain | Emergencies | Children, Only

Turkey
Tarsus University

Completed

Effect of Short Film Video and Video-Based Education on Fear, Pain, and Satisfaction of Children Undergoing Day Surgery

Pain | Fear | Satisfaction | Day Surgery | CHİLDREN

Turkey
Marinus Pharmaceuticals

Completed

A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression

Behavioral Symptoms | Depressive Disorder | Depression | Mood Disorders | Pregnancy Complications | Depression, Postpartum | Mental Disorder | Postpartum Disorder | PPD | Postpartum Blues

United States
Amicus Therapeutics

Available

Expanded Access for ATB200/AT2221 for the Treatment of IOPD

Pompe Disease Infantile-Onset

Taiwan, United States, Italy
Amicus Therapeutics

Available

Expanded Access for ATB200/AT2221 for the Treatment of Pompe Disease

Pompe Disease
Marinus Pharmaceuticals

Completed

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Infantile Spasms

United States
Marinus Pharmaceuticals

Completed

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) (TSC)

Tuberous Sclerosis

United States
Amicus Therapeutics

Active, not recruiting

Long-Term Follow Up of CLN6 Batten Disease Subjects Following Gene Transfer

Batten Disease | CLN6

United States
Marinus Pharmaceuticals

Completed

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 (0602)

Epilepsy, Complex Partial

United States
Amicus Therapeutics

Completed

Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years)

Fabry Disease

United Kingdom, United States
Amicus Therapeutics

Approved for marketing

Physician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry Disease

Fabry Disease

United States, Australia
Amicus Therapeutics

Completed

A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Fabry Disease

Australia, Brazil
Amicus Therapeutics

Completed

A Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Fabry Disease

United States
Amicus Therapeutics

Terminated

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

Fabry Disease

United Kingdom, United States, Australia, Brazil, France
Amicus Therapeutics

Completed

A 24-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease

Fabry Disease

France, United Kingdom
Amicus Therapeutics

Terminated

Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease

Pompe Disease

United States

Clinical Trials Sponsored by Marcus Maurer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations